Your browser doesn't support javascript.
loading
Increased G3BP2-Tau interaction in tauopathies is a natural defense against Tau aggregation.
Wang, Congwei; Terrigno, Marco; Li, Juan; Distler, Tania; Pandya, Nikhil J; Ebeling, Martin; Tyanova, Stefka; Hoozemans, Jeroen J M; Dijkstra, Anke A; Fuchs, Luisa; Xiang, Shengqi; Bonni, Azad; Grüninger, Fiona; Jagasia, Ravi.
Affiliation
  • Wang C; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland. Electronic address: congwei.wang@roche.com.
  • Terrigno M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Li J; School of Life Sciences, University of Science and Technology of China, 230026 Anhui, China.
  • Distler T; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Pandya NJ; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Ebeling M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Tyanova S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Hoozemans JJM; Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, 1081 HV Amsterdam, the Netherlands.
  • Dijkstra AA; Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, 1081 HV Amsterdam, the Netherlands.
  • Fuchs L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Xiang S; School of Life Sciences, University of Science and Technology of China, 230026 Anhui, China.
  • Bonni A; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Grüninger F; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Jagasia R; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland. Electronic address: ravi.jagasia@roche.com.
Neuron ; 111(17): 2660-2674.e9, 2023 09 06.
Article in En | MEDLINE | ID: mdl-37385246
Many RNA-binding proteins (RBPs), particularly those associated with RNA granules, promote pathological protein aggregation in neurodegenerative diseases. Here, we demonstrate that G3BP2, a core component of stress granules, directly interacts with Tau and inhibits Tau aggregation. In the human brain, the interaction of G3BP2 and Tau is dramatically increased in multiple tauopathies, and it is independent of neurofibrillary tangle (NFT) formation in Alzheimer's disease (AD). Surprisingly, Tau pathology is significantly elevated upon loss of G3BP2 in human neurons and brain organoids. Moreover, we found that G3BP2 masks the microtubule-binding region (MTBR) of Tau, thereby inhibiting Tau aggregation. Our study defines a novel role for RBPs as a line of defense against Tau aggregation in tauopathies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tauopathies / Alzheimer Disease Limits: Humans Language: En Journal: Neuron Journal subject: NEUROLOGIA Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tauopathies / Alzheimer Disease Limits: Humans Language: En Journal: Neuron Journal subject: NEUROLOGIA Year: 2023 Type: Article